Board approves Q1 FY27 unaudited financial results

Results View source PDF Explain this filing

ACUTAAS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-5.1%Reaction day

₹3425.00

prior close

₹3409.00

announcement price

In-mkt

timing

Nifty Smallcap 250market-0.3%-4.8% vs market

Pharmaceuticals peers, median of 164sector-0.1%-5.0% vs sector

On the reaction day the stock moved 4.8 pts less than Nifty Smallcap 250 and 5.0 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.9

10m

-2.4

15m

-2.6

30m

-4.1

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-5.1-0.3-4.8-0.1-5.0

Next day

-2.2+1.0-3.1+0.6-2.7

-1.3+0.5-1.8+0.1-1.3

-3.6+1.9-5.5+0.6-4.3

-5.6+1.1-6.7-0.0-5.6

-9.8+1.5-11.4+0.2-10.0

-5.7+3.1-8.8+0.8-6.5

15d

-5.7+3.6-9.3+2.7-8.5

-7.4+4.1-11.5+1.4-8.9

-3.8+2.9-6.7+4.1-7.9

-2.2-6.1+3.9-4.2+2.0

UpDownMarket · Nifty Smallcap 250Sector · Pharmaceuticals peers, median of 164Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Acutaas Chemicals (formerly Ami Organics) announced that its Board, at the July 24, 2026 meeting, approved the Unaudited Standalone and Consolidated Financial Results for Q1 ended June 30, 2026. The results were reviewed by the Audit Committee and accompanied by a Limited Review Report from statutory auditors Maheshwari & Co. No specific financial figures were disclosed in this filing.

Likely market impact

Routine compliance disclosure; detailed Q1 numbers likely in the attached results PDF for shareholders to review.